In the US when the vaccine was first recommended for adolescents in 2005, the expectation was that protection would last for 10 years; however, currently available data suggest it wanes in most adolescents within 5 years. Based on that information, a single dose at the recommended age of 11 or 12 years may not offer protection through the adolescent years at which risk for meningococcal infection is highest (16 though 21 years of age). A booster dose is now recommended at age 16.
- Meningococcal Polysaccharide Vaccine Information for Consumers
- Meningococcal Polysaccharide Vaccine Information for Healthcare Professionals (includes dosage details)
- Side Effects of Meningococcal Polysaccharide Vaccine (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 2 Jun 2013 • 1 answer
Posted 14 Jun 2013 • 1 answer
Hepatitis B adult vaccine- is it safe to get this vaccine in pregnancy.As I am a physiotherapist the
Posted 22 Jan 2014 • 1 answer
Posted 30 Jan 2015 • 1 answer
Posted 10 Feb 2015 • 1 answer